Page last updated: 2024-11-03

ritanserin and Nelson Syndrome

ritanserin has been researched along with Nelson Syndrome in 1 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Nelson Syndrome: A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.

Research Excerpts

ExcerptRelevanceReference
"Ketanserin was given to 2 patients with Nelson's syndrome, with only transient ACTH decrease in one, and no changes in ACTH response to CRH after 1 month treatment in both cases."2.69Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease. ( Belluardo, P; Boscaro, M; Fallo, F; Fava, GA; Franceschetto, A; Sonino, N, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonino, N1
Fava, GA1
Fallo, F1
Franceschetto, A1
Belluardo, P1
Boscaro, M1

Trials

1 trial available for ritanserin and Nelson Syndrome

ArticleYear
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease.
    Pituitary, 2000, Volume: 3, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Female; Hormones; Humans; Hydrocor

2000